Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Not Confirmed
Not Confirmed
03-05 September, 2025
Not Confirmed
Not Confirmed
04-06 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Industry Trade Show
Not Confirmed
03-05 September, 2025
Industry Trade Show
Not Confirmed
04-06 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
03 Jan 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/viatris-closes-acquisitions-of-oyster-point-pharma-and-famy-life-sciences-establishing-new-viatris-eye-care-division-301712041.html
02 Dec 2022
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2022/12/02/2566670/0/en/Oyster-Point-Pharma-Inc-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
08 Nov 2022
// FIERCEPHARMA
https://www.fiercepharma.com/pharma/viatris-jumps-ophthalmology-ring-oyster-point-pharma-and-fany-life-sciences-purchase-700-750
07 Nov 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/11/07/2549667/0/en/Oyster-Point-Pharma-a-Leading-Ophthalmology-Focused-Biopharmaceutical-Company-to-be-Acquired-by-Viatris.html
04 Oct 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/10/04/2527732/0/en/Oyster-Point-Pharma-Inc-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
27 Sep 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/09/27/2523268/0/en/Oyster-Point-Pharma-to-Present-New-Scientific-Analyses-at-World-Cornea-Congress-VIII.html
ABOUT THIS PAGE